Original Literature | Model OverView |
---|---|
Publication
Title
Interferon gene regulation: not all roads lead to Tolls.
Affiliation
Department of Biochemistry and Biotechnology Institute, Trinity College Dublin,Ireland.
Abstract
Many infectious agents elicit a type I interferon response but, until recently,the molecular details that coordinate interferon (IFN)-alpha and -betaexpression during infection were unknown. Innate immune pattern recognitionreceptors, including Toll-like receptors and cytoplasmic RNA helicases such asretinoic acid-inducible gene, that sense viral nucleic acids have beendiscovered. Using distinct mechanisms, these receptors trigger cellularsignaling pathways, culminating in the activation of interferon regulatoryfactors that transcriptionally induce IFN-alpha and IFN-beta genes.
PMID
16095970
|
Entity
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m67
10
infinite
0
TRANSPATH | MO000000058 |
--
TRAF6
--
MO000000212
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m183
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
IRF-3
--
MO000007694
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m977
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
IRF-5
--
MO000007700
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m979
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007700 |
--
IRF-7
--
MO000007702
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m980
10
infinite
0
TRANSPATH | MO000007702 |
--
MyD88
--
MO000016573
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1572
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000016573 |
--
IKK-i {activated}
--
MO000016608
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1599
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016608 |
--
IKK-alpha:IKK-beta:IKK-gamma
--
MO000016661
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1637
10
infinite
0
TRANSPATH | MO000016661 |
--
TBK1 {activated}
--
MO000019331
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3902
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000019331 |
--
dsRNA
--
MO000022224
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m119368
10
infinite
0
TRANSPATH | MO000022224 |
--
IRAK-4
--
MO000039077
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m17258
10
infinite
0
TRANSPATH | MO000039077 |
--
dsRNA:TLR3:TRIF
--
MO000041437
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19305
10
infinite
0
TRANSPATH | MO000041437 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
--
e11
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_IntegralToMembrane_
--
--
--
csml-variable:Double
m11
0
infinite
0
--
--
e12
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_Membrane_
--
--
--
csml-variable:Double
m12
0
infinite
0
--
--
e13
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToInternalSideOfMembrane_
--
--
--
csml-variable:Double
m13
0
infinite
0
--
--
e14
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum
--
--
--
csml-variable:Double
m14
0
infinite
0
--
ssRNA
--
e15
cso30:c:mRNA
cso30:i:CC_Extracellular
--
csml-variable:Double
m15
0
infinite
0
--
csml-variable:Double
m16
0
infinite
0
--
ssRNA: TLR7
--
e17
cso30:c:Complex
cso30:i:CC_EndoplasmicReticulum_IntegralToMembrane_
--
csml-variable:Double
m17
0
infinite
0
--
csml-variable:Double
m18
0
infinite
0
--
dsDNA: TLR9
--
e19
cso30:c:Complex
cso30:i:CC_EndoplasmicReticulum_IntegralToMembrane_
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
csml-variable:Double
m20
0
infinite
0
--
dsRNA: RIG-I
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
csml-variable:Double
m22
0
infinite
0
--
csml-variable:Double
m23
0
infinite
0
--
csml-variable:Double
m24
0
infinite
0
--
IRF3{p}: IRF3: CBP: p300
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
IRF3{p}: IRF3: CBP: p300 {nucleus}
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
imidazoquinolines
--
e27
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m28
0
infinite
0
--
imidazoquinolines: TLR7
--
e28
cso30:c:Complex
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToInternalSideOfMembrane_
--
--
csml-variable:Double
m29
0
infinite
0
--
csml-variable:Double
m30
10
infinite
0
Ensembl | ENSG00000147877 |
HGNC | IFNA7 |
OMIM | 147567 |
Proteome | HumanPSD/IFNA7 |
RefSeq | NM_021057 |
TRANSFAC | G000306 |
Unigene | Hs.282274 |
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
ssRNA: TLR7: MyD88
--
e30
cso30:c:Complex
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToInternalSideOfMembrane_
--
csml-variable:Double
m31
0
infinite
0
--
dsDNA: TLR9: MyD88
--
e31
cso30:c:Complex
cso30:i:CC_EndoplasmicReticulum_IntegralToMembrane_
--
csml-variable:Double
m32
0
infinite
0
--
IRF-7: MyD88
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m33
0
infinite
0
--
LPS: TLR4
--
e34
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m35
0
infinite
0
--
IRF-7 [p}
--
e35
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
LPS: TLR4: MyD88: Mal
--
e36
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m37
0
infinite
0
--
LPS: TLR4: TRIF: TIRAP
--
e37
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m38
0
infinite
0
--
LPS: TLR4: MyD88: Mal: IRAK-1: IRAK-4
--
e38
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m39
0
infinite
0
--
LPS: TLR4: MyD88: Mal: IRAK-1: IRAK-4: Ubc13: Uev1A
--
e39
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
ssRNA: TLR7: MyD88: IRAK-1:IRAK-4
--
e40
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
LPS: TLR4: MyD88: Mal: IRAK-1: IRAK-4: Ubc13: Uev1A: TRAF6
--
e41
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m42
0
infinite
0
--
LPS: TLR4: MyD88: Mal: IRAK-1: IRAK-4: Ubc13: Uev1A: TRAF6 {ub (n)}
--
e42
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m43
0
infinite
0
--
LPS: TLR4: MyD88: Mal: IRAK-1: IRAK-4: Ubc13: Uev1A: TRAF6 {ub (n)}: TAK1: TAB2: TAB3
--
e43
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m44
0
infinite
0
--
LPS: TLR4: MyD88: Mal: IRAK-1: IRAK-4: Ubc13: Uev1A: TRAF6 {ub (n)}: TAK1{activated}: TAB2: TAB3
--
e44
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m45
0
infinite
0
--
IKK-alpha:IKK-beta:IKK-gamma {activated}
--
e45
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m46
10
infinite
0
TRANSPATH | MO000016661 |
--
MEKKs {activated}
--
e46
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m48
10
infinite
0
TRANSPATH | MO000000060 |
--
IRF-7: TRAF6
--
e47
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m49
0
infinite
0
--
csml-variable:Double
m63
10
infinite
0
HGNC | UBE2V1 |
OMIM | 602995 |
Proteome | HumanPSD/UBE2V1 |
RefSeq | NM_001032288 |
TRANSPATH | MO000087842 |
Unigene | Hs.420529 |
UniProt | Q13404-1 |
--
dsDNA: TLR9: MyD88: IRAK-1: IRAK-4
--
e49
cso30:c:Complex
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToInternalSideOfMembrane_
--
csml-variable:Double
m64
0
infinite
0
--
--
e5
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulumLumen
--
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
--
e6
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToExternalSideOfMembrane_
--
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
ssRNA: TLR7: MyD88: IRAK-1:IRAK-4: TRAF6
--
e63
cso30:c:Complex
cso30:i:CC_EndoplasmicReticulumLumen
--
csml-variable:Double
m65
0
infinite
0
--
dsDNA: TLR9: MyD88: IRAK-1: IRAK-4:TRAF6
--
e64
cso30:c:Complex
cso30:i:CC_EndoplasmicReticulum_ExtrinsicToInternalSideOfMembrane_
--
csml-variable:Double
m66
0
infinite
0
--
NF-kappaB {activated}
--
e65
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m68
10
infinite
0
TRANSPATH | MO000000058 |
--
IRF-5 {activated}
--
e66
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m69
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007700 |
--
IRF-5 {nucleus}
--
e67
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m70
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007700 |
--
dsRNA:TLR3:TRIF: RIP1
--
e68
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m72
0
infinite
0
--
dsRNA:TLR3:TRIF: RIP1{ub}
--
e69
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m73
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
csml-variable:Double
m76
10
infinite
0
Affymetrix | 1418930_at |
Ensembl | ENSMUSG00000034855 |
MGD | Cxcl10 |
Proteome | HumanPSD/Cxcl10 |
RefSeq | NM_021274 |
TRANSFAC | G001062 |
Unigene | Mm.263514 |
--
dsRNA: PKR {p}
--
e73
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m77
0
infinite
0
--
dsRNA: RIG-I {activated}
--
e74
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m78
0
infinite
0
--
V protein
--
e75
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m79
0
infinite
0
--
V protein: Mda-5
--
e76
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m80
0
infinite
0
--
dsRNA: RIG-I {activated}: IKK-i: TBK1
--
e77
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m81
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c6 : 1
stoichiometry:c5 : 1
m19314*m18998*0.1
nodelay
--
0
PMID: 16095970, 12539043, 14517278 TLR3 signaling in response to the dsRNA mimetic polyinosinic?polycytidylic acid [poly (I-C)] can also activate IRF3, a process mediated solely by the Toll?interleukin (IL)-1 resistance or receptor (TIR)-domain-containing adaptor-inducing IFN-beta, TRIF.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m24*0.1
nodelay
--
0
PMID: 16095970, 8524823, 9463386, 11846977 In resting cells, IRF3 resides in the cytoplasm. Virus infection results in its signal-dependent phosphorylation, dimerization and interaction with the co-activator proteins CBP and p300.
p11
p11
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m23*m2282*m4512*0.1
nodelay
--
0
PMID: 16095970, 8524823, 9463386, 11846977 In resting cells, IRF3 resides in the cytoplasm. Virus infection results in its signal-dependent phosphorylation, dimerization and interaction with the co-activator proteins CBP and p300.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
m25*0.1
nodelay
--
0
PMID: 16095970 This IRF3-containing complex then translocates to the nucleus to regulate IFN-beta gene transcription.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m26*0.1
nodelay
--
0
PMID: 16095970 This IRF3-containing complex then translocates to the nucleus to regulate IFN-beta gene transcription.
p14
p14
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c40 : 1
stoichiometry:c38 : 1
m977*m3902*0.1
nodelay
--
0
PMID: 16095970, 12702806, 14679297 Both kinases directly phosphorylate IRF3.
p15
p15
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c43 : 1
stoichiometry:c42 : 1
m977*m27*0.1
nodelay
--
0
PMID: 16095970, 15502848 Phosphatidylinositol 3-kinase has also been implicated in IRF3 activation and seems to be required for full activation of IRF3 following TLR3 signaling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
stoichiometry:c46 : 1
m28*m19940*0.1
nodelay
--
0
PMID: 16095970, 11812998 they produce large quantities of IFN-alpha and IFN-beta in response to purified ligands, including imidazoquinolines and ssRNA and for TLR7 or CpG oligonucleotides (CpG-ODNs), as well as certain microbial DNAs, in the case of TLR9.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c156 : 1
stoichiometry:c47 : 1
m70*0.1
nodelay
--
0
PMID: 16095970 IRF5 is also important for IFN-alpha induction.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c48 : 1
m36*0.1
nodelay
--
0
PMID: 16095970 IRF7 is essential for the induction of IFN-alpha and -beta genes via the MyD88-dependent TLR7 and 9 pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c49 : 1
m26*0.1
nodelay
--
0
PMID: 16095970 This IRF3-containing complex then translocates to the nucleus to regulate IFN-beta gene transcription.
p2
p2
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m3965*m119368*0.1
nodelay
--
0
PMID: 16095970, 11607032, 14976261, 11130078, Toll-like receptors (TLRs) 3, 7, 8 and 9 are endosomally localized, membrane-bound receptors which recognize double-stranded (ds)RNA, single-stranded (ss)RNA and dsDNA, respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c146 : 1
stoichiometry:c54 : 1
m36*0.1
nodelay
--
0
PMID: 16095970 IRF7 is essential for the induction of IFN-alpha and -beta genes via the MyD88-dependent TLR7 and 9 pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c56 : 1
stoichiometry:c61 : 1
m17*m1572*0.1
nodelay
--
0
PMID: 16095970, 11130078, 11812998 Upon binding of their ligands, TLR7 and TLR9 recruit myeloid differentiation factor-88 (MyD88) 6 and 44, which is essential for IFN induction by these TLRs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
stoichiometry:c62 : 1
m1572*m19*0.1
nodelay
--
0
PMID: 16095970, 11130078, 11812998 Upon binding of their ligands, TLR7 and TLR9 recruit myeloid differentiation factor-88 (MyD88) 6 and 44, which is essential for IFN induction by these TLRs.
p23
p23
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c60 : 1
stoichiometry:c63 : 1
m1572*m980*0.1
nodelay
--
0
PMID: 16095970, 15492225, 15361868 MyD88 interacts directly with IRF7 52 and 53 but not with IRF3.
p24
p24
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c65 : 1
stoichiometry:c66 : 1
m34*m980*0.1
nodelay
--
0
PMID: 16095970, 8599092 IL-1 receptor-associated kinase (IRAK1), a kinase important for NF-kappaB signaling , is also important for IRF7 activation. PMID: 16095970 IRF7 must be phosphorylated on its carboxy-terminus to be activated.
p25
p25
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c68 : 1
stoichiometry:c69 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 16095970, 10585427, 11896392 11698465 Lipopolysaccharide (LPS), via TLR4, triggers the nuclear translocation and DNA binding of IRF3 and subsequent induction of IFN-beta and IFN-stimulated genes.
p26
p26
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
stoichiometry:c72 : 1
stoichiometry:c73 : 1
m1572*m35*m43675*0.1
nodelay
--
0
PMID: 16095970 TLR4-induced activation of NF-kappaB occurs via the recruitment of MyD88-adapter-like (Mal), Toll?IL-1 receptor (TIR)-domain-containing adaptor protein (TIRAP) and MyD88, which then recruit the downstream serine/threonine kinases IRAK1 and 4.
p27
p27
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
stoichiometry:c76 : 1
stoichiometry:c77 : 1
m35*m6810*m18998*0.1
nodelay
--
0
PMID: 16095970 TLR4-induced activation of NF-kappaB occurs via the recruitment of MyD88-adapter-like (Mal), Toll?IL-1 receptor (TIR)-domain-containing adaptor protein (TIRAP) and MyD88, which then recruit the downstream serine/threonine kinases IRAK1 and 4. PMID: 16095970 A fourth TIR-domain-containing adaptor, TRIF-related adaptor molecule, is required to recruit TRIF to the TLR4 cytoplasmic domain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
stoichiometry:c80 : 1
stoichiometry:c81 : 1
m37*m34*m17258*0.1
nodelay
--
0
PMID: 16095970 TLR4-induced activation of NF-kappaB occurs via the recruitment of MyD88-adapter-like (Mal), Toll?IL-1 receptor (TIR)-domain-containing adaptor protein (TIRAP) and MyD88, which then recruit the downstream serine/threonine kinases IRAK1 and 4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c84 : 1
stoichiometry:c85 : 1
stoichiometry:c83 : 1
m39*m6443*m63*0.1
nodelay
--
0
PMID: 16095970 For NF-kappaB activation, TRAF6 associates with a dimeric E2 (or ubiquitin conjugating enzyme), consisting of Ubc13 and Uev1A.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m15*m19823*0.1
nodelay
--
0
PMID: 16095970, 11607032, 14976261, 11130078, Toll-like receptors (TLRs) 3, 7, 8 and 9 are endosomally localized, membrane-bound receptors which recognize double-stranded (ds)RNA, single-stranded (ss)RNA and dsDNA, respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m40*m183*0.1
nodelay
--
0
PMID: 16095970 For NF-kappaB activation, TRAF6 associates with a dimeric E2 (or ubiquitin conjugating enzyme), consisting of Ubc13 and Uev1A.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
m42*0.1
nodelay
--
0
PMID: 16095970 A dimeric E2 (or ubiquitin-conjugating enzyme) consisting of Ubc13 and Uev1A polyubiquitinated target proteins, including TRAF6.
p32
p32
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c92 : 1
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c95 : 1
m1573*m6433*m19389*m43*0.1
nodelay
--
0
PMID: 16095970, 15327770 K63-polyubiquintated TRAF6 mediates the activation of TAK1-associated proteins TAB2 and TAB3, which interact with K63?ubiquitin chains. PMID: 16095970, 15327770 In fact, the TAK1-associated proteins TAB2 and TAB3 both contain a domain that interacts specifically with K63?ubiquitin chains.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c97 : 1
m44*0.1
nodelay
--
0
PMID: 16095970, 15327770 K63-polyubiquintated TRAF6 mediates the activation of TAK1-associated proteins TAB2 and TAB3, which interact with K63?ubiquitin chains.
p34
p34
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m45*m1637*0.1
nodelay
--
0
PMID: 16095970, 15361868 This model for TLR signaling predicts that the TAK1?TAB complex associates with K63-ubiquitinated TRAF6 to activate TAK1 kinase, which then activates the IKK complex, as well as the JNK kinases (MEKKs).
p35
p35
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m45*m47*0.1
nodelay
--
0
PMID: 16095970, 15361868 This model for TLR signaling predicts that the TAK1?TAB complex associates with K63-ubiquitinated TRAF6 to activate TAK1 kinase, which then activates the IKK complex, as well as the JNK kinases (MEKKs).
p36
p36
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m183*m980*0.1
nodelay
--
0
PMID: 16095970 TRAF6 interacts with IRF7 via its RING finger domain.
p37
p37
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c111 : 1
stoichiometry:c108 : 1
m980*m1599*0.1
nodelay
--
0
PMID: 16095970, 12702806, 15743772 This has been shown to occur through the action of IKKepsilon and/or TBK1, which can directly phosphorylate and activate IRF7.
p38
p38
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c112 : 1
stoichiometry:c110 : 1
m980*m3902*0.1
nodelay
--
0
12702806, 15743772 This has been shown to occur through the action of IKKepsilon and/or TBK1, which can directly phosphorylate and activate IRF7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c114 : 1
stoichiometry:c115 : 1
stoichiometry:c119 : 1
m34*m31*m17258*0.1
nodelay
--
0
PMID: 16095970 IRAK1, IRAK4 and TRAF6 also function downstream to mediate all of these events.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m16*m19828*0.1
nodelay
--
0
PMID: 16095970, 11607032, 14976261, 11130078, Toll-like receptors (TLRs) 3, 7, 8 and 9 are endosomally localized, membrane-bound receptors which recognize double-stranded (ds)RNA, single-stranded (ss)RNA and dsDNA, respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
stoichiometry:c118 : 1
stoichiometry:c120 : 1
m34*m17258*m32*0.1
nodelay
--
0
PMID: 16095970 IRAK1, IRAK4 and TRAF6 also function downstream to mediate all of these events.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c122 : 1
stoichiometry:c123 : 1
m183*m41*0.1
nodelay
--
0
PMID: 16095970 IRAK1, IRAK4 and TRAF6 also function downstream to mediate all of these events.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c125 : 1
stoichiometry:c126 : 1
m183*m64*0.1
nodelay
--
0
PMID: 16095970 IRAK1, IRAK4 and TRAF6 also function downstream to mediate all of these events.
p43
p43
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c127 : 1
stoichiometry:c52 : 1
m67*m46*0.1
nodelay
--
0
PMID: 16095970 The IKK complex is then activated, leading to NF-kappaB activation.
p44
p44
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c133 : 1
stoichiometry:c129 : 1
m67*m65*0.1
nodelay
--
0
PMID: 16095970 MyD88 interacts with, and is required for activation of, the transcription factors NF-kappaB, IRF5 and IRF7 in response to stimulation of TLR7- and TLR9-specific ligands.
p45
p45
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c130 : 1
stoichiometry:c132 : 1
stoichiometry:c131 : 1
m67*m66*0.1
nodelay
--
0
PMID: 16095970 MyD88 interacts with, and is required for activation of, the transcription factors NF-kappaB, IRF5 and IRF7 in response to stimulation of TLR7- and TLR9-specific ligands.
p46
p46
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c136 : 1
stoichiometry:c135 : 1
m980*m65*0.1
nodelay
--
0
PMID: 16095970 MyD88 interacts with, and is required for activation of, the transcription factors NF-kappaB, IRF5 and IRF7 in response to stimulation of TLR7- and TLR9-specific ligands.
p47
p47
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c137 : 1
stoichiometry:c139 : 1
m980*m66*0.1
nodelay
--
0
PMID: 16095970 MyD88 interacts with, and is required for activation of, the transcription factors NF-kappaB, IRF5 and IRF7 in response to stimulation of TLR7- and TLR9-specific ligands.
p48
p48
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c140 : 1
stoichiometry:c144 : 1
stoichiometry:c141 : 1
m979*m65*0.1
nodelay
--
0
PMID: 16095970 MyD88 interacts with, and is required for activation of, the transcription factors NF-kappaB, IRF5 and IRF7 in response to stimulation of TLR7- and TLR9-specific ligands.
p49
p49
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c142 : 1
stoichiometry:c145 : 1
stoichiometry:c143 : 1
m979*m66*0.1
nodelay
--
0
PMID: 16095970 MyD88 interacts with, and is required for activation of, the transcription factors NF-kappaB, IRF5 and IRF7 in response to stimulation of TLR7- and TLR9-specific ligands.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m15*m19940*0.1
nodelay
--
0
PMID: 16095970, 11607032, 14976261, 11130078, Toll-like receptors (TLRs) 3, 7, 8 and 9 are endosomally localized, membrane-bound receptors which recognize double-stranded (ds)RNA, single-stranded (ss)RNA and dsDNA, respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c149 : 1
stoichiometry:c148 : 1
m69*m65*0.1
nodelay
--
0
PMID: 16095970, 15695821 Engagement of TLR7 or 8 by R-848 results in IRF5 nuclear translocation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c152 : 1
stoichiometry:c151 : 1
m69*m18*0.1
nodelay
--
0
PMID: 16095970, 15695821 Engagement of TLR7 or 8 by R-848 results in IRF5 nuclear translocation.
p52
p52
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c155 : 1
stoichiometry:c154 : 1
m979*m19305*0.1
nodelay
--
0
PMID: 16095970 IRF5 is activated in response to TLR3.
p53
p53
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c157 : 1
stoichiometry:c158 : 1
stoichiometry:c159 : 1
m71*m19305*0.1
nodelay
--
0
PMID: 16095970 TLR3 uses RIP1, which might also be ubiquitinated by TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c160 : 1
stoichiometry:c162 : 1
stoichiometry:c161 : 1
m72*m183*0.1
nodelay
--
0
PMID: 16095970 TLR3 uses RIP1, which might also be ubiquitinated by TRAF6.
p55
p55
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c167 : 1
stoichiometry:c172 : 1
stoichiometry:c168 : 1
m74*m19305*0.1
nodelay
--
0
PMID: 16095970 Both TLR3- and TLR4-mediated activation of IRF3 and 7 and the induction of IFN-beta occur in a MyD88-independent manner and require TRIF and the IKK-related kinases IKKepsilon and TBK1.
p56
p56
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c165 : 1
stoichiometry:c174 : 1
stoichiometry:c166 : 1
m75*m38*0.1
nodelay
--
0
PMID: 16095970 Both TLR3- and TLR4-mediated activation of IRF3 and 7 and the induction of IFN-beta occur in a MyD88-independent manner and require TRIF and the IKK-related kinases IKKepsilon and TBK1.
p57
p57
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c163 : 1
stoichiometry:c171 : 1
stoichiometry:c164 : 1
m75*m19305*0.1
nodelay
--
0
PMID: 16095970 Both TLR3- and TLR4-mediated activation of IRF3 and 7 and the induction of IFN-beta occur in a MyD88-independent manner and require TRIF and the IKK-related kinases IKKepsilon and TBK1.
p58
p58
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c169 : 1
stoichiometry:c173 : 1
stoichiometry:c170 : 1
m74*m38*0.1
nodelay
--
0
PMID: 16095970 Both TLR3- and TLR4-mediated activation of IRF3 and 7 and the induction of IFN-beta occur in a MyD88-independent manner and require TRIF and the IKK-related kinases IKKepsilon and TBK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c175 : 1
stoichiometry:c177 : 1
m93217*0.1
nodelay
--
0
PMID: 16095970, 9786932, 9822609 The current dogma suggests that IRF3 mediates the early induction of IFN-beta, which then induces IRF7 via IFN-stimulated gene factor-3 signaling.
p6
p6
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c203 : 1
stoichiometry:c18 : 1
m119368*m76904*0.1
nodelay
--
0
PMID: 16095970, 15208624, 15563593 Cytoplasmic RNA helicases, including retinoic acid-inducible gene (RIG-I) and melanoma differentiation-associated gene-5 (Mda-5) also bind dsRNA. PMID: 16095970 a highly conserved cysteine-rich carboxy-terminal region of paramyxovirus V proteins binds Mda-5, and in so doing inhibits dsRNAinduced IFN-beta production.
p60
p60
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c178 : 1
stoichiometry:c176 : 1
m1636*0.1
nodelay
--
0
PMID: 16095970, 9786932, 9822609 The current dogma suggests that IRF3 mediates the early induction of IFN-beta, which then induces IRF7 via IFN-stimulated gene factor-3 signaling.
p61
p61
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c179 : 1
stoichiometry:c180 : 1
m19305*0.1
nodelay
--
0
PMID: 16095970, 15731229 Rudd et al. found that respiratory syncytial virus-induced IFN-gamma-induced protein-10 (IP-10) and RANTES, but neither CXCL8 production nor viral replication, were impaired in the absence of TLR3.
p62
p62
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c181 : 1
stoichiometry:c182 : 1
m19305*0.1
nodelay
--
0
PMID: 16095970, 15731229 Rudd et al. found that respiratory syncytial virus-induced IFN-gamma-induced protein-10 (IP-10) and RANTES, but neither CXCL8 production nor viral replication, were impaired in the absence of TLR3.
p63
p63
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c183 : 1
stoichiometry:c184 : 1
m19305*0.1
nodelay
--
0
PMID: 16095970 A higher viral titer in the serum of TLR3-deficient mice was observed, and reduced levels of IL-6, TNF-alpha and IFN-beta detected in TLR3-deficient mice.
p64
p64
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c186 : 1
stoichiometry:c185 : 1
m19305*0.1
nodelay
--
0
PMID: 16095970 A higher viral titer in the serum of TLR3-deficient mice was observed, and reduced levels of IL-6, TNF-alpha and IFN-beta detected in TLR3-deficient mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c187 : 1
stoichiometry:c188 : 1
m22*0.1
nodelay
--
0
PMID: 16095970 The double-stranded RNA-activated protein kinase R (PKR) was the first of such cytoplasmic proteins described that could recognize and bind viral dsRNA. PMID: 16095970 PKR is activated by autophosphorylation upon binding to dsRNA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c189 : 1
stoichiometry:c190 : 1
m21*0.1
nodelay
--
0
PMID: 16095970, 15208624 Yoneyama et al. showed that RIG-I binds dsRNA [poly (I-C)] via its RNA helicase domain and is activated by dsRNA.
p67
p67
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c191 : 1
stoichiometry:c199 : 1
stoichiometry:c192 : 1
m980*m81*0.1
nodelay
--
0
PMID: 16095970 It is likely that a downstream effector CARD is then recruited to trigger the activation of IRF3 and IRF7, probably via IKK3, TBK1 and NF-kappaB activation via IKKalpha, beta and gamma.
p68
p68
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c194 : 1
stoichiometry:c210 : 1
stoichiometry:c195 : 1
m1637*m81*0.1
nodelay
--
0
PMID: 16095970 It is likely that a downstream effector CARD is then recruited to trigger the activation of IRF3 and IRF7, probably via IKK3, TBK1 and NF-kappaB activation via IKKalpha, beta and gamma.
p69
p69
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c197 : 1
stoichiometry:c196 : 1
stoichiometry:c193 : 1
m977*m81*0.1
nodelay
--
0
PMID: 16095970 It is likely that a downstream effector CARD is then recruited to trigger the activation of IRF3 and IRF7, probably via IKK3, TBK1 and NF-kappaB activation via IKKalpha, beta and gamma.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m119368*m41844*0.1
nodelay
--
0
PMID: 16095970, 15208624, 15563593 Cytoplasmic RNA helicases, including retinoic acid-inducible gene (RIG-I) and melanoma differentiation-associated gene-5 (Mda-5) also bind dsRNA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c200 : 1
stoichiometry:c201 : 1
stoichiometry:c202 : 1
m79*m76904*0.1
nodelay
--
0
PMID: 16095970 a highly conserved cysteine-rich carboxy-terminal region of paramyxovirus V proteins binds Mda-5, and in so doing inhibits dsRNAinduced IFN-beta production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c205 : 1
stoichiometry:c204 : 1
m20*0.1
nodelay
--
0
PMID: 16095970 a highly conserved cysteine-rich carboxy-terminal region of paramyxovirus V proteins binds Mda-5, and in so doing inhibits dsRNAinduced IFN-beta production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c206 : 1
stoichiometry:c207 : 1
stoichiometry:c209 : 1
stoichiometry:c208 : 1
m75*m78*m74*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m119368*m1055*0.1
nodelay
--
0
PMID: 16095970 Protein kinase R, another cytosolic receptor for dsRNA has also been implicated in antiviral responses.
p9
p9
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c39 : 1
stoichiometry:c26 : 1
m977*m1599*0.1
nodelay
--
0
PMID: 16095970, 8524823, 9463386, 11846977 In resting cells, IRF3 resides in the cytoplasm. Virus infection results in its signal-dependent phosphorylation, dimerization and interaction with the co-activator proteins CBP and p300. PMID: 16095970, 12702806, 14679297 Both kinases directly phosphorylate IRF3.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--